Kawasaki disease: Is it caused by an infectious agent?

British Journal of Biomedical Science

Volumn 58, Issue 2, 2001, Pages 122-128

  Lloyd, Allyson J ^a   Walker, Colin ^a   Wilkinson, Myra ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Infection; Kawasaki disease; Mucocutaneous lymph node syndrome

Indexed keywords

ANTIBODY SPECIFICITY; DIAGNOSTIC TEST; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE;

BACTERIAL INFECTIONS; HUMANS; INFECTION; MUCOCUTANEOUS LYMPH NODE SYNDROME; SUPERANTIGENS;

EID: 0034978739     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jap J Allergy 1967; 16: 178-222.
2. Kawasaki T, Kosai F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-6.
3. Kahn G. Mucocutaneous lymph node syndrome (Kawasaki's disease) - a new disease remaking its debut. Arch Dermatol 1978; 114: 948-50.
4. Curtis N. Kawasaki disease. BMJ 1997; 315: 322-3.
5. Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1998; 11: 405-14.
6. Kato H, Inoue O, Akagi T. Kawasaki disease: cardiac problems and management. Pediatr Rev 1988; 9: 209-17.
7. Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis 1999; 28: 169-87.
8. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976; 130: 599-607.
9. Rose V. Kawasaki syndrome - cardiovascular manifestations. J Rheumatol Suppl 1990; 17(Suppl 24): 11-4.
10. Rider LG, Mendelman PM, French J, Sherry DD. Group A streptococcal infection and Kawasaki syndrome. Lancet 1991; 337: 1100-1.
11. Hirohisa K, Fujimoto T, Inoue O et al. Variant strain of Propionbacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet 1983; ii: 1383-8.
12. Rowley AH, Wolinsky SM, Relman DA et al. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994; 36: 567-71.
13. Harnden A. Kawasaki disease - a diagnostic challenge. Br J Gen Pract 1999; Oct: 779-80.
14. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986; ii: 545-6.
15. Lin C-Y, Chen I-C, Cheng T-I, Liu W-T, Hwang B, Chiang BN. Virus-like particles with reverse transcriptase activity associated with Kawasaki disease. J Med Virol 1992; 38: 175-82.
16. Rowley AH, Shulman ST. Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J 1988; 7: 663-6.
17. Rowley AH, Castro B, Levy J et al. Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome. Pediatr Res 1991; 29: 417-9.
18. Melish ME, Marchette NJ, Kaplan JC, Kihara S, Ching D, Ho DD. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature 1989; 337: 288-90.
19. Nigro G, Zerbini M, Krzysztofiak A et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994; 343: 1260-1.
20. Barbour AG, Krueger GG, Feorino PM, Smith CB. Kawasaki-like disease in a young adult - association with primary Epstein-Barr virus infection. JAMA 1979; 241: 397-8.
21. Swaby ED, Fisher-Hoch S, Lambert HP, Stern H. Is Kawasaki disease a variant of Q fever? Lancet 1980; ii: 146.
22. Carter RF, Haynes ME. Rickettsia-like bodies and splenitis in Kawasaki disease. Lancet 1976; ii: 1254-5.
23. Edlinger EA, Benichou JJ, Labrune B. Positive Ehrlichia canis serology in Kawasaki disease. Lancet 1980; i: 1146-7.
24. Odeh M, Oliven A. Chlamydia infections of the heart: a review. Eur J Clin Microbiol Infect Dis 1992; 11: 885-93.
25. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996; 2: 307-19.
26. Khono T, Takese Y, Niki H. Chlamydia infections in Kawasaki disease. Acta Pediatr 1991; 33: 408-10.
27. Normann E, Naas J, Gnarpe J, Backman H, Gnarpe H. Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease. Pediatr Infect Dis J 1999; 18: 72-3.
28. Schrag SJ, Besser RE, Olson C et al. Lack of association between Kawasaki disease and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Pediatr Infect Dis J 2000; 19: 17-22.
29. Abe J, Kotzin BL, Meissner C et al. Characterization of T-cell repertoire changes in acute Kawasaki disease. J Exp Med 1993; 177: 791-6.
30. Melish ME, Parsonett J, Marchette N. Kawasaki syndrome (KS) is not caused by toxic shock syndrome toxin-1 and staphylococci. Pediatr Res 1994; 35: 187A.
31. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. TCR Vβ family repertoire and T-cell activation markers in Kawasaki disease. J Immunol 1994; 153: 1881-8.
32. Meissner HC, Leung DYM. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J 2000; 19: 91-4.
33. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993; 342: 1385-8.
34. Terai M, Miwa K, Williams T et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995; 172: 558-61.
35. Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J 1999; 18: 69-70.
36. Lin FYC, Bailowitz A, Koslowe P, Israel E, Kaslow RA. Kawasaki syndrome - a case-control study during an outbreak in Maryland. AJDC 1985; 139: 277-9.
37. Yanagawa H, Nakamura Y, Kawasaki T, Shigematsu I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet 1986; ii: 1138-9.
38. Rauch AM, Glode MP, Wiggins JW et al. Outbreak of Kawasaki syndrome in Denver, Colorado; association with rug and carpet cleaning. Pediatrics 1991; 87: 663-9.
39. Davis RL, Waller PL, Mueller BA, Dykewicz CA, Schonberger LB. Kawasaki syndrome in Washington State - race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med 1995; 149: 66-9.
40. Dean AG, Melish ME, Hicks R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr 1982; 100; 552-7.
41. Kato S, Kimura M, Tsuji K et al. HLA antigens in Kawasaki disease. Pediatrics 1978; 61: 252-5.
42. Patriarca PA, Rogers MF, Morens DM, Schonberger LB, Kaminski RM. Kawasaki syndrome: association with the application of rug shampoo. Lancet 1982; ii: 578-80.
43. Daniels SR, Specker B, Association of rug shampooing and Kawasaki disease. J Pediatr 1991; 188; 485-8.
44. Rogers MF, Kochel RL, Hurwitz ES, Jillson CA, Hanrahan JP, Schonberger LB. Kawasaki syndrome; is exposure to rug shampoo important? Am J Dis Child 1985; 139; 777-9.
45. Rauch AM, Kaplan SL, Nihill MR, Pappas PG, Hurwitz ES, Schonberger LB. Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina. Am J Dis Child 1988; 142: 441-4.
46. Cheek DB, Kawasaki T. Comment on mucocutaneous lymph node syndrome: could it be heavy-metal poisoning? Pediatrics 1975; 56: 335-7.
47. Orlowski JP, Mercer RD. Urine mercury levels in Kawasaki disease. Pediatrics 1980; 66: 633-6.